Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,696 | 126 | 97.4% |
| Education | $99.99 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $659.75 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $275.39 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $267.79 | 4 | $0 (2024) |
| Eisai Inc. | $261.22 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $214.03 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $193.76 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $170.42 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $136.06 | 4 | $0 (2024) |
| PFIZER INC. | $135.20 | 6 | $0 (2024) |
| GENZYME CORPORATION | $135.04 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,607 | 62 | AstraZeneca Pharmaceuticals LP ($184.74) |
| 2023 | $2,189 | 65 | AstraZeneca Pharmaceuticals LP ($475.01) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | SEAGEN INC. | — | Education | In-kind items and services | $99.99 | General |
| 11/26/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.33 | General |
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Oncology | ||||||
| 10/20/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 09/23/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Fresenius Kabi USA, LLC | Stimufend (Biological) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Biosimilars | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: HEMATOLOGY | ||||||
| 08/21/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Oncology | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Oncology | ||||||
| 08/16/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $75.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 413 | 852 | $165,581 | $56,571 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 364 | $89,726 | $32,393 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 224 | $36,493 | $13,416 | 36.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 35 | $12,303 | $4,397 | 35.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 72 | $16,049 | $3,982 | 24.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $5,586 | $1,162 | 20.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 34 | 42 | $2,807 | $434.70 | 15.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 37 | 46 | $1,298 | $350.06 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 33 | 37 | $830.04 | $310.80 | 37.4% |
| 83735 | Magnesium level | Office | 2023 | 13 | 19 | $488.75 | $124.83 | 25.5% |
About Cara O'brien
Cara O'brien is a Nurse Practitioner healthcare provider based in Orland Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2022. The National Provider Identifier (NPI) number assigned to this provider is 1992414437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cara O'brien has received a total of $3,796 in payments from pharmaceutical and medical device companies, with $1,607 received in 2024. These payments were reported across 127 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,696).
As a Medicare-enrolled provider, O'brien has provided services to 413 Medicare beneficiaries, totaling 852 services with total Medicare billing of $56,571. Data is available for 1 year (2023–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Orland Park, IL
- Active Since 11/22/2022
- Last Updated 06/09/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1992414437
Products in Payments
- ZEPZELCA (Drug) $275.39
- CALQUENCE (Drug) $270.41
- Lenvima (Drug) $261.22
- KEYTRUDA (Biological) $214.03
- ENHERTU (Biological) $211.13
- OPDIVO (Biological) $182.17
- LIBTAYO (Biological) $136.06
- CABLIVI (Biological) $110.70
- LYNPARZA (Drug) $92.60
- VERZENIO (Drug) $87.09
- REBLOZYL (Biological) $85.62
- MONJUVI (Drug) $84.29
- NINLARO (Drug) $80.13
- Enhertu (Drug) $66.99
- IMFINZI (Biological) $66.70
- Nubeqa (Drug) $65.46
- Stimufend (Biological) $63.08
- INLYTA (Drug) $56.26
- OGSIVEO (Drug) $53.28
- VEGZELMA (Biological) $52.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Orland Park
Lauren Burns
Nurse Practitioner — Payments: $8,412
Ewa Blachowicz, Np,Apn, NP,APN
Nurse Practitioner — Payments: $6,599
Cristyn Savoia, Aprn, Cnp, APRN, CNP
Nurse Practitioner — Payments: $5,907
Holly Clark, N.p, N.P
Nurse Practitioner — Payments: $5,784
Lauren Gesell, Aprn, Cnp, APRN, CNP
Nurse Practitioner — Payments: $4,580
Kimberly Van Wyngarden, Aprn-Bc, APRN-BC
Nurse Practitioner — Payments: $2,994